Symphony™ Randomized Controlled Trial Demonstrates Significantly Improved Healing of Diabetic Foot Ulcers

Data ReadoutpositiveSymphonyPositive

AI Analysis

Summary

Aroa Biosurgery announced positive multicenter randomized controlled trial results for Symphony in diabetic foot ulcers, demonstrating significantly higher complete wound closure rates and faster healing compared to standard of care alone.

Clinical Trial Data

Primary Endpoint

Met

Outcome Details

Multicenter randomized controlled trial demonstrated higher complete wound closure rates and faster healing with Symphony plus standard of care compared to standard of care alone

Importance:7/10

Sentiment:

0.80

Symphony trialdiabetic foot ulcerswound healingsoft tissue regenerationrandomized controlled trialpositive data

Related Companies

$ARX

Read the original article

Published by PR Newswire Pharma on October 5, 2026 4:46 AM

Read Original